- Home
- SMC vs TNGX Comparison
SMC vs TNGX Comparison
Compare SMC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMC
- TNGX
- Stock Information
- Founded
- SMC 2009
- TNGX 2014
- Country
- SMC United States
- TNGX United States
- Employees
- SMC N/A
- TNGX N/A
- Industry
- SMC
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- SMC
- TNGX Health Care
- Exchange
- SMC NYSE
- TNGX Nasdaq
- Market Cap
- SMC 322.4M
- TNGX 351.2M
- IPO Year
- SMC 2012
- TNGX N/A
- Fundamental
- Price
- SMC $25.29
- TNGX $5.63
- Analyst Decision
- SMC
- TNGX Strong Buy
- Analyst Count
- SMC 0
- TNGX 6
- Target Price
- SMC N/A
- TNGX $12.20
- AVG Volume (30 Days)
- SMC 161.4K
- TNGX 3.4M
- Earning Date
- SMC 08-07-2025
- TNGX 08-06-2025
- Dividend Yield
- SMC N/A
- TNGX N/A
- EPS Growth
- SMC N/A
- TNGX N/A
- EPS
- SMC N/A
- TNGX N/A
- Revenue
- SMC $444,383,000.00
- TNGX $40,990,000.00
- Revenue This Year
- SMC N/A
- TNGX N/A
- Revenue Next Year
- SMC N/A
- TNGX N/A
- P/E Ratio
- SMC N/A
- TNGX N/A
- Revenue Growth
- SMC N/A
- TNGX 10.09
- 52 Week Low
- SMC $23.53
- TNGX $1.03
- 52 Week High
- SMC $45.89
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- SMC 46.24
- TNGX 77.32
- Support Level
- SMC $23.53
- TNGX $4.80
- Resistance Level
- SMC $26.13
- TNGX $5.63
- Average True Range (ATR)
- SMC 0.96
- TNGX 0.52
- MACD
- SMC 0.04
- TNGX -0.03
- Stochastic Oscillator
- SMC 50.57
- TNGX 83.33
About SMC SUMMIT MIDSTREAM CORPORATION
Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.